These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 1554922
1. Patterns of prescribing isotretinoin: focus on women of childbearing potential. Doering PL, Araujo OE, Frohnapple DJ, LaMarre AS, Flowers FP. Ann Pharmacother; 1992 Feb; 26(2):155-61. PubMed ID: 1554922 [Abstract] [Full Text] [Related]
4. Survey of Australian isotretinoin prescribing. Lee ML, Cooper A. Australas J Dermatol; 1991 Feb; 32(1):13-6. PubMed ID: 1834043 [Abstract] [Full Text] [Related]
8. Survey of Australian dermatologists' perceptions and experiences with isotretinoin-induced depression and suicide. Rea S, Tucker S, Frittelli V, Gunnarsson R. Australas J Dermatol; 2017 Nov; 58(4):323-324. PubMed ID: 28726271 [No Abstract] [Full Text] [Related]
10. The pattern of topical corticosteroid prescribing in the United States, 1989-1991. Stern RS. J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016 [Abstract] [Full Text] [Related]
12. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. Mitchell AA, Van Bennekom CM, Louik C. N Engl J Med; 1995 Jul 13; 333(2):101-6. PubMed ID: 7777014 [Abstract] [Full Text] [Related]
13. Depression and the dermatologist: a critical analysis of contemporary isotretinoin prescribing practices. Daunton A, Oyebode F, Goulding JMR. Clin Exp Dermatol; 2019 Dec 13; 44(8):903-905. PubMed ID: 30912853 [Abstract] [Full Text] [Related]
14. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study. Crijns I, Mantel-Teeuwisse A, Bloemberg R, Pinas E, Straus S, de Jong-van den Berg L. Expert Opin Drug Saf; 2013 Jan 13; 12(1):29-38. PubMed ID: 23163396 [Abstract] [Full Text] [Related]
15. A cross-sectional survey of knowledge, attitudes, and practice in the prescription of isotretinoin for transgender patients among academic dermatologists. Ensslin CJ, Khanijow K, Yenokyan G, Loss M. J Am Acad Dermatol; 2019 Dec 13; 81(6):1426-1429. PubMed ID: 31648856 [No Abstract] [Full Text] [Related]
16. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Azoulay L, Oraichi D, Bérard A. Eur J Clin Pharmacol; 2006 Aug 13; 62(8):667-74. PubMed ID: 16791584 [Abstract] [Full Text] [Related]
17. Prescribing attitudes of different physician groups regarding fluoxetine. Levin GM, DeVane CL. Ann Pharmacother; 1993 Dec 13; 27(12):1443-7. PubMed ID: 8305772 [Abstract] [Full Text] [Related]
18. Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertainties. Manuelpillai N, Veysey E. Clin Exp Dermatol; 2022 Apr 13; 47(4):770-773. PubMed ID: 34856005 [Abstract] [Full Text] [Related]
19. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea. Hurley MP, Stafford RS, Lane AT. JAMA Dermatol; 2014 May 13; 150(5):487-93. PubMed ID: 24740450 [Abstract] [Full Text] [Related]